Vericel Corp (NASDAQ: VCEL) kicked off on Tuesday, up 2.32% from the previous trading day, before settling in for the closing price of $42.65. Over the past 52 weeks, VCEL has traded in a range of $37.39-$63.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.33% over the past five years. While this was happening, its average annual earnings per share was recorded 18.12%. With a float of $49.79 million, this company’s outstanding shares have now reached $50.25 million.
Let’s look at the performance matrix of the company that is accounted for 357 employees. In terms of profitability, gross margin is 72.54%, operating margin of -1.18%, and the pretax margin is 1.31%.
Vericel Corp (VCEL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vericel Corp is 1.09%, while institutional ownership is 106.63%. The most recent insider transaction that took place on May 07 ’25, was worth 279,860. In this transaction Director of this company sold 7,000 shares at a rate of $39.98, taking the stock ownership to the 15,100 shares. Before that another transaction happened on May 07 ’25, when Company’s Director proposed sale 7,000 for $39.98, making the entire transaction worth $279,878.
Vericel Corp (VCEL) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 18.12% per share during the next fiscal year.
Vericel Corp (NASDAQ: VCEL) Trading Performance Indicators
Take a look at Vericel Corp’s (VCEL) current performance indicators. Last quarter, stock had a quick ratio of 4.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.04, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.73 in one year’s time.
Technical Analysis of Vericel Corp (VCEL)
Vericel Corp (NASDAQ: VCEL) saw its 5-day average volume 0.84 million, a positive change from its year-to-date volume of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 80.97%. Additionally, its Average True Range was 2.21.
During the past 100 days, Vericel Corp’s (VCEL) raw stochastic average was set at 24.40%, which indicates a significant decrease from 89.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.88% in the past 14 days, which was lower than the 46.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.45, while its 200-day Moving Average is $49.29. Nevertheless, the first resistance level for the watch stands at $44.75 in the near term. At $45.86, the stock is likely to face the second major resistance level. The third major resistance level sits at $47.31. If the price goes on to break the first support level at $42.19, it is likely to go to the next support level at $40.74. Assuming the price breaks the second support level, the third support level stands at $39.63.
Vericel Corp (NASDAQ: VCEL) Key Stats
The company with the Market Capitalisation of 2.20 billion has total of 50,343K Shares Outstanding. Its annual sales at the moment are 237,220 K in contrast with the sum of 10,360 K annual income. Company’s last quarter sales were recorded 52,600 K and last quarter income was -11,250 K.
